Skip to main content

Table 4 Multivariable associations between patient characteristics and the prevalence of synovitis

From: Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis

Model term

OR

95% CI for OR

P value

Gender

   

   Female

1.104

0.279–4.659

1.000

   Male

1

  

Disease duration, years

   

   <1

1.772

0.416–8.270

0.576

   1 to <2.5

3.926

0.722–25.120

0.133

   2.5 to <6

0.908

0.176–4.711

1.000

   ≥ 6

1

  

Age, years

   

   <40

1.423

0.3217–6.597

0.837

   40 to <50

1.307

0.2818–6.179

0.951

   50 to <60

1.258

0.205–7.421

1.000

   ≥ 60

1

  

Anti-CCP

   

   Positive

7.611

1.475–74.870

0.010

   Negative

1

  

SSA

   

   Positive

1.588

0.376–7.413

0.691

   Negative

1

  

SSB

   

   Positive

0.393

0.130–0.967

0.084

   Negative

1

  
  1. Anti-CCP, cyclic citrullinated peptide antibody; CI, confidence interval; OR, prevalence odds ratio.